Uncategorized
Ophthotech reports $39.6 million net loss in third quarter
Ophthotech reported a net loss of $39.6 million, or $1.14 per diluted share, in the third quarter compared with a net income of $8.6 million, or $0.25 per diluted share, in the third quarter of 2014, according to a press release. The 2014 income was attributed to a $50 million enrollment-based milestone achieved under a licensing and commercialization agreement with Novartis.